Global Liposomes Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
The global Liposomes market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Liposomes Industry Forecast” looks at past sales and reviews total world Liposomes sales in 2023, providing a comprehensive analysis by region and market sector of projected Liposomes sales for 2024 through 2030. With Liposomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes industry.
This Insight Report provides a comprehensive analysis of the global Liposomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposomes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Liposomes market?
What factors are driving Liposomes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposomes market opportunities vary by end market size?
How does Liposomes break out type, application?
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
The global Liposomes market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Liposomes Industry Forecast” looks at past sales and reviews total world Liposomes sales in 2023, providing a comprehensive analysis by region and market sector of projected Liposomes sales for 2024 through 2030. With Liposomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes industry.
This Insight Report provides a comprehensive analysis of the global Liposomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposomes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
- Spectrum Pharmaceuticals
- Shanghai New Asia
What is the 10-year outlook for the global Liposomes market?
What factors are driving Liposomes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposomes market opportunities vary by end market size?
How does Liposomes break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposomes Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Liposomes by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Liposomes by Country/Region, 2019, 2023 & 2030
2.2 Liposomes Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposomes Sales by Type
2.3.1 Global Liposomes Sales Market Share by Type (2019-2024)
2.3.2 Global Liposomes Revenue and Market Share by Type (2019-2024)
2.3.3 Global Liposomes Sale Price by Type (2019-2024)
2.4 Liposomes Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposomes Sales by Application
2.5.1 Global Liposomes Sale Market Share by Application (2019-2024)
2.5.2 Global Liposomes Revenue and Market Share by Application (2019-2024)
2.5.3 Global Liposomes Sale Price by Application (2019-2024)
3 GLOBAL LIPOSOMES BY COMPANY
3.1 Global Liposomes Breakdown Data by Company
3.1.1 Global Liposomes Annual Sales by Company (2019-2024)
3.1.2 Global Liposomes Sales Market Share by Company (2019-2024)
3.2 Global Liposomes Annual Revenue by Company (2019-2024)
3.2.1 Global Liposomes Revenue by Company (2019-2024)
3.2.2 Global Liposomes Revenue Market Share by Company (2019-2024)
3.3 Global Liposomes Sale Price by Company
3.4 Key Manufacturers Liposomes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposomes Product Location Distribution
3.4.2 Players Liposomes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION
4.1 World Historic Liposomes Market Size by Geographic Region (2019-2024)
4.1.1 Global Liposomes Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Liposomes Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Liposomes Market Size by Country/Region (2019-2024)
4.2.1 Global Liposomes Annual Sales by Country/Region (2019-2024)
4.2.2 Global Liposomes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Liposomes Sales Growth
4.4 APAC Liposomes Sales Growth
4.5 Europe Liposomes Sales Growth
4.6 Middle East & Africa Liposomes Sales Growth
5 AMERICAS
5.1 Americas Liposomes Sales by Country
5.1.1 Americas Liposomes Sales by Country (2019-2024)
5.1.2 Americas Liposomes Revenue by Country (2019-2024)
5.2 Americas Liposomes Sales by Type
5.3 Americas Liposomes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomes Sales by Region
6.1.1 APAC Liposomes Sales by Region (2019-2024)
6.1.2 APAC Liposomes Revenue by Region (2019-2024)
6.2 APAC Liposomes Sales by Type
6.3 APAC Liposomes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposomes by Country
7.1.1 Europe Liposomes Sales by Country (2019-2024)
7.1.2 Europe Liposomes Revenue by Country (2019-2024)
7.2 Europe Liposomes Sales by Type
7.3 Europe Liposomes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposomes by Country
8.1.1 Middle East & Africa Liposomes Sales by Country (2019-2024)
8.1.2 Middle East & Africa Liposomes Revenue by Country (2019-2024)
8.2 Middle East & Africa Liposomes Sales by Type
8.3 Middle East & Africa Liposomes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomes
10.3 Manufacturing Process Analysis of Liposomes
10.4 Industry Chain Structure of Liposomes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposomes Distributors
11.3 Liposomes Customer
12 WORLD FORECAST REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION
12.1 Global Liposomes Market Size Forecast by Region
12.1.1 Global Liposomes Forecast by Region (2025-2030)
12.1.2 Global Liposomes Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liposomes Forecast by Type
12.7 Global Liposomes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Liposomes Product Portfolios and Specifications
13.1.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Liposomes Product Portfolios and Specifications
13.2.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Pacira
13.3.1 Pacira Company Information
13.3.2 Pacira Liposomes Product Portfolios and Specifications
13.3.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pacira Main Business Overview
13.3.5 Pacira Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Liposomes Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposomes Product Portfolios and Specifications
13.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Information
13.6.2 Sigma-Tau Group Liposomes Product Portfolios and Specifications
13.6.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sigma-Tau Group Main Business Overview
13.6.5 Sigma-Tau Group Latest Developments
13.7 Fudan-Zhangjiang
13.7.1 Fudan-Zhangjiang Company Information
13.7.2 Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
13.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fudan-Zhangjiang Main Business Overview
13.7.5 Fudan-Zhangjiang Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Liposomes Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 CSPC
13.9.1 CSPC Company Information
13.9.2 CSPC Liposomes Product Portfolios and Specifications
13.9.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CSPC Main Business Overview
13.9.5 CSPC Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposomes Product Portfolios and Specifications
13.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Kingond Pharm
13.11.1 Kingond Pharm Company Information
13.11.2 Kingond Pharm Liposomes Product Portfolios and Specifications
13.11.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Kingond Pharm Main Business Overview
13.11.5 Kingond Pharm Latest Developments
13.12 Spectrum Pharmaceuticals
13.12.1 Spectrum Pharmaceuticals Company Information
13.12.2 Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
13.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Spectrum Pharmaceuticals Main Business Overview
13.12.5 Spectrum Pharmaceuticals Latest Developments
13.13 Shanghai New Asia
13.13.1 Shanghai New Asia Company Information
13.13.2 Shanghai New Asia Liposomes Product Portfolios and Specifications
13.13.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Shanghai New Asia Main Business Overview
13.13.5 Shanghai New Asia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposomes Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Liposomes by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Liposomes by Country/Region, 2019, 2023 & 2030
2.2 Liposomes Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposomes Sales by Type
2.3.1 Global Liposomes Sales Market Share by Type (2019-2024)
2.3.2 Global Liposomes Revenue and Market Share by Type (2019-2024)
2.3.3 Global Liposomes Sale Price by Type (2019-2024)
2.4 Liposomes Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposomes Sales by Application
2.5.1 Global Liposomes Sale Market Share by Application (2019-2024)
2.5.2 Global Liposomes Revenue and Market Share by Application (2019-2024)
2.5.3 Global Liposomes Sale Price by Application (2019-2024)
3 GLOBAL LIPOSOMES BY COMPANY
3.1 Global Liposomes Breakdown Data by Company
3.1.1 Global Liposomes Annual Sales by Company (2019-2024)
3.1.2 Global Liposomes Sales Market Share by Company (2019-2024)
3.2 Global Liposomes Annual Revenue by Company (2019-2024)
3.2.1 Global Liposomes Revenue by Company (2019-2024)
3.2.2 Global Liposomes Revenue Market Share by Company (2019-2024)
3.3 Global Liposomes Sale Price by Company
3.4 Key Manufacturers Liposomes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposomes Product Location Distribution
3.4.2 Players Liposomes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION
4.1 World Historic Liposomes Market Size by Geographic Region (2019-2024)
4.1.1 Global Liposomes Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Liposomes Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Liposomes Market Size by Country/Region (2019-2024)
4.2.1 Global Liposomes Annual Sales by Country/Region (2019-2024)
4.2.2 Global Liposomes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Liposomes Sales Growth
4.4 APAC Liposomes Sales Growth
4.5 Europe Liposomes Sales Growth
4.6 Middle East & Africa Liposomes Sales Growth
5 AMERICAS
5.1 Americas Liposomes Sales by Country
5.1.1 Americas Liposomes Sales by Country (2019-2024)
5.1.2 Americas Liposomes Revenue by Country (2019-2024)
5.2 Americas Liposomes Sales by Type
5.3 Americas Liposomes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomes Sales by Region
6.1.1 APAC Liposomes Sales by Region (2019-2024)
6.1.2 APAC Liposomes Revenue by Region (2019-2024)
6.2 APAC Liposomes Sales by Type
6.3 APAC Liposomes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposomes by Country
7.1.1 Europe Liposomes Sales by Country (2019-2024)
7.1.2 Europe Liposomes Revenue by Country (2019-2024)
7.2 Europe Liposomes Sales by Type
7.3 Europe Liposomes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposomes by Country
8.1.1 Middle East & Africa Liposomes Sales by Country (2019-2024)
8.1.2 Middle East & Africa Liposomes Revenue by Country (2019-2024)
8.2 Middle East & Africa Liposomes Sales by Type
8.3 Middle East & Africa Liposomes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomes
10.3 Manufacturing Process Analysis of Liposomes
10.4 Industry Chain Structure of Liposomes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposomes Distributors
11.3 Liposomes Customer
12 WORLD FORECAST REVIEW FOR LIPOSOMES BY GEOGRAPHIC REGION
12.1 Global Liposomes Market Size Forecast by Region
12.1.1 Global Liposomes Forecast by Region (2025-2030)
12.1.2 Global Liposomes Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liposomes Forecast by Type
12.7 Global Liposomes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Liposomes Product Portfolios and Specifications
13.1.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Liposomes Product Portfolios and Specifications
13.2.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Pacira
13.3.1 Pacira Company Information
13.3.2 Pacira Liposomes Product Portfolios and Specifications
13.3.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pacira Main Business Overview
13.3.5 Pacira Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Liposomes Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposomes Product Portfolios and Specifications
13.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Information
13.6.2 Sigma-Tau Group Liposomes Product Portfolios and Specifications
13.6.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sigma-Tau Group Main Business Overview
13.6.5 Sigma-Tau Group Latest Developments
13.7 Fudan-Zhangjiang
13.7.1 Fudan-Zhangjiang Company Information
13.7.2 Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
13.7.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Fudan-Zhangjiang Main Business Overview
13.7.5 Fudan-Zhangjiang Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Liposomes Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 CSPC
13.9.1 CSPC Company Information
13.9.2 CSPC Liposomes Product Portfolios and Specifications
13.9.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CSPC Main Business Overview
13.9.5 CSPC Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposomes Product Portfolios and Specifications
13.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Kingond Pharm
13.11.1 Kingond Pharm Company Information
13.11.2 Kingond Pharm Liposomes Product Portfolios and Specifications
13.11.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Kingond Pharm Main Business Overview
13.11.5 Kingond Pharm Latest Developments
13.12 Spectrum Pharmaceuticals
13.12.1 Spectrum Pharmaceuticals Company Information
13.12.2 Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
13.12.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Spectrum Pharmaceuticals Main Business Overview
13.12.5 Spectrum Pharmaceuticals Latest Developments
13.13 Shanghai New Asia
13.13.1 Shanghai New Asia Company Information
13.13.2 Shanghai New Asia Liposomes Product Portfolios and Specifications
13.13.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Shanghai New Asia Main Business Overview
13.13.5 Shanghai New Asia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Liposomes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Liposomes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposomes Sales by Type (2019-2024) & (K Units)
Table 8. Global Liposomes Sales Market Share by Type (2019-2024)
Table 9. Global Liposomes Revenue by Type (2019-2024) & ($ million)
Table 10. Global Liposomes Revenue Market Share by Type (2019-2024)
Table 11. Global Liposomes Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Liposomes Sales by Application (2019-2024) & (K Units)
Table 13. Global Liposomes Sales Market Share by Application (2019-2024)
Table 14. Global Liposomes Revenue by Application (2019-2024)
Table 15. Global Liposomes Revenue Market Share by Application (2019-2024)
Table 16. Global Liposomes Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Liposomes Sales by Company (2019-2024) & (K Units)
Table 18. Global Liposomes Sales Market Share by Company (2019-2024)
Table 19. Global Liposomes Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Liposomes Revenue Market Share by Company (2019-2024)
Table 21. Global Liposomes Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Liposomes Producing Area Distribution and Sales Area
Table 23. Players Liposomes Products Offered
Table 24. Liposomes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Liposomes Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Liposomes Sales Market Share Geographic Region (2019-2024)
Table 29. Global Liposomes Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Liposomes Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Liposomes Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Liposomes Sales Market Share by Country/Region (2019-2024)
Table 33. Global Liposomes Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Liposomes Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Liposomes Sales by Country (2019-2024) & (K Units)
Table 36. Americas Liposomes Sales Market Share by Country (2019-2024)
Table 37. Americas Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Liposomes Revenue Market Share by Country (2019-2024)
Table 39. Americas Liposomes Sales by Type (2019-2024) & (K Units)
Table 40. Americas Liposomes Sales by Application (2019-2024) & (K Units)
Table 41. APAC Liposomes Sales by Region (2019-2024) & (K Units)
Table 42. APAC Liposomes Sales Market Share by Region (2019-2024)
Table 43. APAC Liposomes Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Liposomes Revenue Market Share by Region (2019-2024)
Table 45. APAC Liposomes Sales by Type (2019-2024) & (K Units)
Table 46. APAC Liposomes Sales by Application (2019-2024) & (K Units)
Table 47. Europe Liposomes Sales by Country (2019-2024) & (K Units)
Table 48. Europe Liposomes Sales Market Share by Country (2019-2024)
Table 49. Europe Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Liposomes Revenue Market Share by Country (2019-2024)
Table 51. Europe Liposomes Sales by Type (2019-2024) & (K Units)
Table 52. Europe Liposomes Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Liposomes Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Liposomes Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Liposomes Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Liposomes Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Liposomes Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Liposomes
Table 60. Key Market Challenges & Risks of Liposomes
Table 61. Key Industry Trends of Liposomes
Table 62. Liposomes Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Liposomes Distributors List
Table 65. Liposomes Customer List
Table 66. Global Liposomes Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Liposomes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Liposomes Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Liposomes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Liposomes Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Liposomes Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Liposomes Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Liposomes Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Johnson & Johnson Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson Liposomes Product Portfolios and Specifications
Table 82. Johnson & Johnson Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. Gilead Sciences Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 86. Gilead Sciences Liposomes Product Portfolios and Specifications
Table 87. Gilead Sciences Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Latest Developments
Table 90. Pacira Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 91. Pacira Liposomes Product Portfolios and Specifications
Table 92. Pacira Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pacira Main Business
Table 94. Pacira Latest Developments
Table 95. Sun Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 96. Sun Pharmaceutical Liposomes Product Portfolios and Specifications
Table 97. Sun Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Main Business
Table 99. Sun Pharmaceutical Latest Developments
Table 100. Luye Pharma Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 101. Luye Pharma Liposomes Product Portfolios and Specifications
Table 102. Luye Pharma Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Luye Pharma Main Business
Table 104. Luye Pharma Latest Developments
Table 105. Sigma-Tau Group Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 106. Sigma-Tau Group Liposomes Product Portfolios and Specifications
Table 107. Sigma-Tau Group Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sigma-Tau Group Main Business
Table 109. Sigma-Tau Group Latest Developments
Table 110. Fudan-Zhangjiang Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 111. Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
Table 112. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Fudan-Zhangjiang Main Business
Table 114. Fudan-Zhangjiang Latest Developments
Table 115. Teva Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 116. Teva Pharmaceutical Liposomes Product Portfolios and Specifications
Table 117. Teva Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceutical Main Business
Table 119. Teva Pharmaceutical Latest Developments
Table 120. CSPC Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 121. CSPC Liposomes Product Portfolios and Specifications
Table 122. CSPC Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. CSPC Main Business
Table 124. CSPC Latest Developments
Table 125. Novartis Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 126. Novartis Liposomes Product Portfolios and Specifications
Table 127. Novartis Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Novartis Main Business
Table 129. Novartis Latest Developments
Table 130. Kingond Pharm Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 131. Kingond Pharm Liposomes Product Portfolios and Specifications
Table 132. Kingond Pharm Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Kingond Pharm Main Business
Table 134. Kingond Pharm Latest Developments
Table 135. Spectrum Pharmaceuticals Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 136. Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
Table 137. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Spectrum Pharmaceuticals Main Business
Table 139. Spectrum Pharmaceuticals Latest Developments
Table 140. Shanghai New Asia Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 141. Shanghai New Asia Liposomes Product Portfolios and Specifications
Table 142. Shanghai New Asia Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shanghai New Asia Main Business
Table 144. Shanghai New Asia Latest Developments
Table 1. Liposomes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Liposomes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposomes Sales by Type (2019-2024) & (K Units)
Table 8. Global Liposomes Sales Market Share by Type (2019-2024)
Table 9. Global Liposomes Revenue by Type (2019-2024) & ($ million)
Table 10. Global Liposomes Revenue Market Share by Type (2019-2024)
Table 11. Global Liposomes Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Liposomes Sales by Application (2019-2024) & (K Units)
Table 13. Global Liposomes Sales Market Share by Application (2019-2024)
Table 14. Global Liposomes Revenue by Application (2019-2024)
Table 15. Global Liposomes Revenue Market Share by Application (2019-2024)
Table 16. Global Liposomes Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Liposomes Sales by Company (2019-2024) & (K Units)
Table 18. Global Liposomes Sales Market Share by Company (2019-2024)
Table 19. Global Liposomes Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Liposomes Revenue Market Share by Company (2019-2024)
Table 21. Global Liposomes Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Liposomes Producing Area Distribution and Sales Area
Table 23. Players Liposomes Products Offered
Table 24. Liposomes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Liposomes Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Liposomes Sales Market Share Geographic Region (2019-2024)
Table 29. Global Liposomes Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Liposomes Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Liposomes Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Liposomes Sales Market Share by Country/Region (2019-2024)
Table 33. Global Liposomes Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Liposomes Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Liposomes Sales by Country (2019-2024) & (K Units)
Table 36. Americas Liposomes Sales Market Share by Country (2019-2024)
Table 37. Americas Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Liposomes Revenue Market Share by Country (2019-2024)
Table 39. Americas Liposomes Sales by Type (2019-2024) & (K Units)
Table 40. Americas Liposomes Sales by Application (2019-2024) & (K Units)
Table 41. APAC Liposomes Sales by Region (2019-2024) & (K Units)
Table 42. APAC Liposomes Sales Market Share by Region (2019-2024)
Table 43. APAC Liposomes Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Liposomes Revenue Market Share by Region (2019-2024)
Table 45. APAC Liposomes Sales by Type (2019-2024) & (K Units)
Table 46. APAC Liposomes Sales by Application (2019-2024) & (K Units)
Table 47. Europe Liposomes Sales by Country (2019-2024) & (K Units)
Table 48. Europe Liposomes Sales Market Share by Country (2019-2024)
Table 49. Europe Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Liposomes Revenue Market Share by Country (2019-2024)
Table 51. Europe Liposomes Sales by Type (2019-2024) & (K Units)
Table 52. Europe Liposomes Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Liposomes Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Liposomes Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Liposomes Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Liposomes Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Liposomes Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Liposomes Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Liposomes
Table 60. Key Market Challenges & Risks of Liposomes
Table 61. Key Industry Trends of Liposomes
Table 62. Liposomes Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Liposomes Distributors List
Table 65. Liposomes Customer List
Table 66. Global Liposomes Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Liposomes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Liposomes Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Liposomes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Liposomes Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Liposomes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Liposomes Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Liposomes Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Liposomes Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Liposomes Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Johnson & Johnson Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson & Johnson Liposomes Product Portfolios and Specifications
Table 82. Johnson & Johnson Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Main Business
Table 84. Johnson & Johnson Latest Developments
Table 85. Gilead Sciences Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 86. Gilead Sciences Liposomes Product Portfolios and Specifications
Table 87. Gilead Sciences Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Latest Developments
Table 90. Pacira Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 91. Pacira Liposomes Product Portfolios and Specifications
Table 92. Pacira Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pacira Main Business
Table 94. Pacira Latest Developments
Table 95. Sun Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 96. Sun Pharmaceutical Liposomes Product Portfolios and Specifications
Table 97. Sun Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Main Business
Table 99. Sun Pharmaceutical Latest Developments
Table 100. Luye Pharma Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 101. Luye Pharma Liposomes Product Portfolios and Specifications
Table 102. Luye Pharma Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Luye Pharma Main Business
Table 104. Luye Pharma Latest Developments
Table 105. Sigma-Tau Group Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 106. Sigma-Tau Group Liposomes Product Portfolios and Specifications
Table 107. Sigma-Tau Group Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sigma-Tau Group Main Business
Table 109. Sigma-Tau Group Latest Developments
Table 110. Fudan-Zhangjiang Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 111. Fudan-Zhangjiang Liposomes Product Portfolios and Specifications
Table 112. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Fudan-Zhangjiang Main Business
Table 114. Fudan-Zhangjiang Latest Developments
Table 115. Teva Pharmaceutical Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 116. Teva Pharmaceutical Liposomes Product Portfolios and Specifications
Table 117. Teva Pharmaceutical Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Teva Pharmaceutical Main Business
Table 119. Teva Pharmaceutical Latest Developments
Table 120. CSPC Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 121. CSPC Liposomes Product Portfolios and Specifications
Table 122. CSPC Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. CSPC Main Business
Table 124. CSPC Latest Developments
Table 125. Novartis Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 126. Novartis Liposomes Product Portfolios and Specifications
Table 127. Novartis Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Novartis Main Business
Table 129. Novartis Latest Developments
Table 130. Kingond Pharm Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 131. Kingond Pharm Liposomes Product Portfolios and Specifications
Table 132. Kingond Pharm Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Kingond Pharm Main Business
Table 134. Kingond Pharm Latest Developments
Table 135. Spectrum Pharmaceuticals Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 136. Spectrum Pharmaceuticals Liposomes Product Portfolios and Specifications
Table 137. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Spectrum Pharmaceuticals Main Business
Table 139. Spectrum Pharmaceuticals Latest Developments
Table 140. Shanghai New Asia Basic Information, Liposomes Manufacturing Base, Sales Area and Its Competitors
Table 141. Shanghai New Asia Liposomes Product Portfolios and Specifications
Table 142. Shanghai New Asia Liposomes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shanghai New Asia Main Business
Table 144. Shanghai New Asia Latest Developments
LIST OF FIGURES
Figure 1. Picture of Liposomes
Figure 2. Liposomes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomes Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Liposomes Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Liposomes Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Liposomal Doxorubicin
Figure 10. Product Picture of Liposomal Amphoteracin B
Figure 11. Product Picture of Liposomal Paclitaxel
Figure 12. Product Picture of Others
Figure 13. Global Liposomes Sales Market Share by Type in 2023
Figure 14. Global Liposomes Revenue Market Share by Type (2019-2024)
Figure 15. Liposomes Consumed in Fungal Infection Therapy
Figure 16. Global Liposomes Market: Fungal Infection Therapy (2019-2024) & (K Units)
Figure 17. Liposomes Consumed in Cancer & Tumor Therapy
Figure 18. Global Liposomes Market: Cancer & Tumor Therapy (2019-2024) & (K Units)
Figure 19. Liposomes Consumed in Others
Figure 20. Global Liposomes Market: Others (2019-2024) & (K Units)
Figure 21. Global Liposomes Sales Market Share by Application (2023)
Figure 22. Global Liposomes Revenue Market Share by Application in 2023
Figure 23. Liposomes Sales Market by Company in 2023 (K Units)
Figure 24. Global Liposomes Sales Market Share by Company in 2023
Figure 25. Liposomes Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Liposomes Revenue Market Share by Company in 2023
Figure 27. Global Liposomes Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Liposomes Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Liposomes Sales 2019-2024 (K Units)
Figure 30. Americas Liposomes Revenue 2019-2024 ($ Millions)
Figure 31. APAC Liposomes Sales 2019-2024 (K Units)
Figure 32. APAC Liposomes Revenue 2019-2024 ($ Millions)
Figure 33. Europe Liposomes Sales 2019-2024 (K Units)
Figure 34. Europe Liposomes Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Liposomes Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Liposomes Revenue 2019-2024 ($ Millions)
Figure 37. Americas Liposomes Sales Market Share by Country in 2023
Figure 38. Americas Liposomes Revenue Market Share by Country in 2023
Figure 39. Americas Liposomes Sales Market Share by Type (2019-2024)
Figure 40. Americas Liposomes Sales Market Share by Application (2019-2024)
Figure 41. United States Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Liposomes Sales Market Share by Region in 2023
Figure 46. APAC Liposomes Revenue Market Share by Regions in 2023
Figure 47. APAC Liposomes Sales Market Share by Type (2019-2024)
Figure 48. APAC Liposomes Sales Market Share by Application (2019-2024)
Figure 49. China Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Liposomes Sales Market Share by Country in 2023
Figure 57. Europe Liposomes Revenue Market Share by Country in 2023
Figure 58. Europe Liposomes Sales Market Share by Type (2019-2024)
Figure 59. Europe Liposomes Sales Market Share by Application (2019-2024)
Figure 60. Germany Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Liposomes Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Liposomes Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Liposomes Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Liposomes Sales Market Share by Application (2019-2024)
Figure 69. Egypt Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Liposomes in 2023
Figure 75. Manufacturing Process Analysis of Liposomes
Figure 76. Industry Chain Structure of Liposomes
Figure 77. Channels of Distribution
Figure 78. Global Liposomes Sales Market Forecast by Region (2025-2030)
Figure 79. Global Liposomes Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Liposomes Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Liposomes Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Liposomes Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Liposomes Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Liposomes
Figure 2. Liposomes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomes Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Liposomes Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Liposomes Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Liposomal Doxorubicin
Figure 10. Product Picture of Liposomal Amphoteracin B
Figure 11. Product Picture of Liposomal Paclitaxel
Figure 12. Product Picture of Others
Figure 13. Global Liposomes Sales Market Share by Type in 2023
Figure 14. Global Liposomes Revenue Market Share by Type (2019-2024)
Figure 15. Liposomes Consumed in Fungal Infection Therapy
Figure 16. Global Liposomes Market: Fungal Infection Therapy (2019-2024) & (K Units)
Figure 17. Liposomes Consumed in Cancer & Tumor Therapy
Figure 18. Global Liposomes Market: Cancer & Tumor Therapy (2019-2024) & (K Units)
Figure 19. Liposomes Consumed in Others
Figure 20. Global Liposomes Market: Others (2019-2024) & (K Units)
Figure 21. Global Liposomes Sales Market Share by Application (2023)
Figure 22. Global Liposomes Revenue Market Share by Application in 2023
Figure 23. Liposomes Sales Market by Company in 2023 (K Units)
Figure 24. Global Liposomes Sales Market Share by Company in 2023
Figure 25. Liposomes Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Liposomes Revenue Market Share by Company in 2023
Figure 27. Global Liposomes Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Liposomes Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Liposomes Sales 2019-2024 (K Units)
Figure 30. Americas Liposomes Revenue 2019-2024 ($ Millions)
Figure 31. APAC Liposomes Sales 2019-2024 (K Units)
Figure 32. APAC Liposomes Revenue 2019-2024 ($ Millions)
Figure 33. Europe Liposomes Sales 2019-2024 (K Units)
Figure 34. Europe Liposomes Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Liposomes Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Liposomes Revenue 2019-2024 ($ Millions)
Figure 37. Americas Liposomes Sales Market Share by Country in 2023
Figure 38. Americas Liposomes Revenue Market Share by Country in 2023
Figure 39. Americas Liposomes Sales Market Share by Type (2019-2024)
Figure 40. Americas Liposomes Sales Market Share by Application (2019-2024)
Figure 41. United States Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Liposomes Sales Market Share by Region in 2023
Figure 46. APAC Liposomes Revenue Market Share by Regions in 2023
Figure 47. APAC Liposomes Sales Market Share by Type (2019-2024)
Figure 48. APAC Liposomes Sales Market Share by Application (2019-2024)
Figure 49. China Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Liposomes Sales Market Share by Country in 2023
Figure 57. Europe Liposomes Revenue Market Share by Country in 2023
Figure 58. Europe Liposomes Sales Market Share by Type (2019-2024)
Figure 59. Europe Liposomes Sales Market Share by Application (2019-2024)
Figure 60. Germany Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Liposomes Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Liposomes Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Liposomes Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Liposomes Sales Market Share by Application (2019-2024)
Figure 69. Egypt Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Liposomes Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Liposomes in 2023
Figure 75. Manufacturing Process Analysis of Liposomes
Figure 76. Industry Chain Structure of Liposomes
Figure 77. Channels of Distribution
Figure 78. Global Liposomes Sales Market Forecast by Region (2025-2030)
Figure 79. Global Liposomes Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Liposomes Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Liposomes Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Liposomes Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Liposomes Revenue Market Share Forecast by Application (2025-2030)
